Today: 11 July 2025
4 October 2023
1 min read

Viatris Completes $1.2B Divestiture In India

Viatris has executed an agreement to divest its API business in India to Iquest Enterprises…reports Asian Lite News

Viatris (formerly known as Mylan Inc) has finalised two deals in India to divest its API (active pharmaceutical ingredients) and women’s healthcare businesses for a combined consideration of around $1.2 billion, the healthcare company said on Monday.

The United States-headquartered global healthcare company has centres in Pittsburgh, Shanghai, and Hyderabad.

Viatris has executed an agreement to divest its API business in India to Iquest Enterprises, a Hyderabad-based pharmaceutical company owned by Nimmagadda Prasad, the founder of Matrix Laboratories.

The transaction includes three manufacturing sites and a R&D lab in Hyderabad, three manufacturing sites in Vizag and third-party API sales. However, Viatris will retain some selective R&D capabilities in API.

The women’s healthcare business, which primarily relates to oral and injectable contraceptives, has been sold to Insud Pharma, a leading Spanish multinational pharmaceutical company. The deal includes two manufacturing facilities in India: one in Ahmedabad and the other in Sarigam.

Both the India deals are expected to close in Q1 2024, according to the Viatris statement. Jefferies and law firm Saraf & Partners were the advisors for the deal.

Viatris has also sold its OTC (over- the- counter) business in Europe and commercialisation rights in a few non-core markets as part of a global divestiture drive to pare debt.

“With this announcement the company has delivered its commitment to announce agreements on all planned divestitures by the end of 2023 within the company’s previously communicated range, after considering the estimated retained value,” the Viatris statement read.

“Including gross proceeds from the company’s completed biosimilars divestiture, the company expects to realize gross proceeds representing a multiple above 12x on 2022 estimated adjusted EBITDA for its portfolio of divested assets.

“The gross proceeds to the company from all divestitures under the terms of the agreements are up to $6.94 billion, or up to approximately $5.2 billion in estimated aggregate net proceeds, taking into consideration taxes and other costs, including related transaction costs,” the statement added.

ALSO READ: Aspire.io Acquires Commerceup

Previous Story

Etihad Airways Pulls Out Of Dhaka Routes

Next Story

Indian Shooting Stars Blaze A Trail At Asian Games

Latest from Business

Apple Appoints Sabih Khan as New COO

Khan will take over from Jeff Williams, who is stepping down from the role this month and will retire later this year…reports Asian Lite News Apple has announced that Sabih Khan, an

Northeast Is Growth Engine

Scindia also provided updates on the government’s efforts to facilitate the entry of SpaceX’s Starlink service into India. “All due diligence from the Ministry’s side is complete Union Minister for Communications and

India to Empower Global South

India is emerging as a pivotal force in the global transition to clean energy, with Union Minister for New and Renewable Energy, Pralhad Joshi, asserting that the country is empowering the Global

Maruti’s Global Push Breaks Record

June shipments hit 37,842 units, signalling robust global demand Maruti Suzuki India recorded its highest-ever monthly exports in June, shipping 37,842 units and marking a new milestone that highlights the company’s expanding

Qatar Debut For Tata

Tata Motors emphasised that its international offerings are backed by strong research and development capabilities, with vehicles that are thoroughly tested and adapted to local conditions Tata Motors has unveiled its all-new
Go toTop

Don't Miss

India pacer Jhulan becomes joint leading wicket-taker

In her first spell against New Zealand, Jhulan had 0/34

Union Cabinet approves MoU between India and Armenia

The MoU will come into effect from the date of